These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 2227807)

  • 1. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
    Wanless IR; Lentz JS
    Hepatology; 1990 Nov; 12(5):1106-10. PubMed ID: 2227807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases from the spectrum of nonalcoholic steatohepatitis.
    Abdelmalek M; Ludwig J; Lindor KD
    J Clin Gastroenterol; 1995 Mar; 20(2):127-30. PubMed ID: 7769192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity: danger for the hepatocytes?].
    Selvais PL; Henrion J
    Acta Clin Belg; 1992; 47(5):329-37. PubMed ID: 1334321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response.
    Charatcharoenwitthaya P; Pongpaibul A; Kaosombatwattana U; Bhanthumkomol P; Bandidniyamanon W; Pausawasdi N; Tanwandee T
    Liver Int; 2017 Apr; 37(4):542-551. PubMed ID: 27740738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis.
    Dixon JB
    Clin Liver Dis; 2007 Feb; 11(1):141-54, ix-x. PubMed ID: 17544976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity.
    Duchini A; Brunson ME
    Transplantation; 2001 Jul; 72(1):156-9. PubMed ID: 11468551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis.
    Saadeh S; Younossi ZM
    Cleve Clin J Med; 2000 Feb; 67(2):96-7, 101-4. PubMed ID: 10680276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis in obesity: a reversible condition.
    Eriksson S; Eriksson KF; Bondesson L
    Acta Med Scand; 1986; 220(1):83-8. PubMed ID: 3766211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonalcoholic steatohepatitis (NASH)].
    Ishii H; Okuyama K
    Ryoikibetsu Shokogun Shirizu; 1995; (8):28-31. PubMed ID: 8581628
    [No Abstract]   [Full Text] [Related]  

  • 16. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic steatohepatitis.
    Kumar KS; Malet PF
    Mayo Clin Proc; 2000 Jul; 75(7):733-9. PubMed ID: 10907390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver pathology in obesity.
    Suriawinata A; Fiel MI
    Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity.
    García-Monzón C; Martín-Pérez E; Iacono OL; Fernández-Bermejo M; Majano PL; Apolinario A; Larrañaga E; Moreno-Otero R
    J Hepatol; 2000 Nov; 33(5):716-24. PubMed ID: 11097478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis.
    Jansen PL
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1079-85. PubMed ID: 15489564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.